Pentetreotide (DrugBank: Pentetreotide)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 75 | Cushing disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00001849 (ClinicalTrials.gov) | February 26, 1999 | 3/11/1999 | New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome | New Imaging Modalities in the Evaluation of Patients With Ectopic Cushing's Syndrome | Cushing Syndrome;Endocrine Disease | Drug: Pentetreotide;Drug: 18F-DOPA | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | NULL | Completed | 18 Years | 90 Years | All | 98 | Phase 1;Phase 2 | United States |